COMT and Dystonia: These data suggest that G/G and A/A genotype polymorphisms of COMT gene are associated with a protective effect for developing collateral extrapyramidal symptoms in patients treated with APDs; on the other hand, the G/A genotype, almost exclusively present in APDS patients, could be considered as a risk factor for developing dystonia after administration of APDs.